USANA Health Sciences Inc (NYSE:USNA)
| 58.58 Delayed Data As of 3:59pm ET |  -1.18 / -1.97%Today’s Change | 48.61 Today|||52-Week Range 69.60 | +10.11% Year-to-Date |
Latest USNA News | Press Releases
| USNA vs. ZTS: Which Stock Is the Better Value Option? Sep 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 59.76 |
| Today’s open | 59.50 |
| Day’s range | 58.29 - 59.81 |
| Volume | 58,374 |
| Average volume (3 months) | 65,881 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -37.72% |
| Earnings growth (this year) | -15.76% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | -15.83% |
| P/E ratio | 17.8 |
| Price/Sales | 1.03 |
| Price/Book | 2.66 |
Competitors
| ---- | ||
| CRONCronos Group Inc | -0.07 | -3.21% |
| --Abivax SA | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | October 24, 2023 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $998.6M |
| Annual profit (last year) | $69.4M |
| Net profit margin | 6.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
